Home›Compare›Oak Longevity vs Raeliva

Oak Longevity vs Raeliva: Which Is Better?

Head-to-head comparison of Oak Longevity and Raeliva based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Raeliva scores higher overall in our independent evaluation (61.2/100 vs 60.3/100), leading on trust & safety, value. Oak Longevity comes out ahead on experience, product range, reputation. Oak Longevity has the lower entry price (from $79/mo vs $117/mo), so the better value depends on which treatment you need.

Oak Longevity ('Oak Loves You') is a small cash-pay telehealth brand selling compounded GLP-1s, ED medication and NAD+/sermorelin. Headline prices require multi-month plans, and orders become non-refundable once sent to the pharmacy.

Visit Oak Longevity
61

Raeliva is a 2026-launched GLP-1 and longevity storefront built on the CareValidate platform, with flat dose-independent pricing and prepay discounts.

Visit Raeliva

Score Breakdown

DimensionOak LongevityRaeliva
Overall Score60.3/10061.2/100 ✓
Trust & Safety30%55/10060/100 ✓
Value25%66/10072/100 ✓
Experience20%64/100 ✓62/100
Product Range15%62/100 ✓55/100
Reputation10%52/100 ✓45/100

At a Glance

Founded20242026
Headquarters—San Diego, CA
Publicly tradedNoNo
Treatment categories32
Treatments listed57
Starting price$79/mo$117/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryOak LongevityRaeliva
Weight Loss / GLP-1$130–$235
Compounded Semaglutide
$150–$219
Compounded Semaglutide Injections
Longevity & Peptides$99
NAD+ Injections
$117–$179
NAD+

Oak Longevity

+Compounded semaglutide from about $130/mo on multi-month plans, flat across doses
+Positive Trustpilot base (4.4/5, 54 reviews) citing fast approvals and responsive messaging
+Range spans GLP-1s, ED (tadalafil), NAD+ and sermorelin under one account
−Homepage 'from $89/mo' pricing is well below the ~$235/mo (semaglutide) and ~$285/mo (tirzepatide) one-month checkout prices
−Orders become non-refundable once sent to the pharmacy; mandatory arbitration and class-action waiver
−Opaque structure: three legal entity names, a Vancouver, BC BBB registration, and unnamed pharmacies and leadership
Read the full Oak Longevity review →

Raeliva

+Clear operator disclosure: names the platform operator, the billing/intake vendor (CareValidate), the medical group (Lion MDs, with physician NPIs) and six dispensing pharmacies
+Flat pricing at every dose for semaglutide and tirzepatide, published on each product page
+Accepts transfers at the patient's current GLP-1 dose after provider review, with no charge if not eligible
−Launched in 2026 with ~1,500 claimed patients and only 12 Trustpilot reviews, all five-star and posted within two months
−Lowest advertised rates require 6- or 12-month prepayment ($900–1,450 upfront), and dispensed medication is non-refundable
−Runs on CareValidate's white-label telehealth stack, so the clinical and billing experience is shared with other storefronts
Read the full Raeliva review →

Oak Longevity vs Raeliva — FAQ

Is Oak Longevity better than Raeliva?

▾

Raeliva scores higher overall in our independent evaluation (61.2/100 vs 60.3/100), leading on trust & safety, value. Oak Longevity comes out ahead on experience, product range, reputation. Oak Longevity has the lower entry price (from $79/mo vs $117/mo), so the better value depends on which treatment you need.

Is Oak Longevity or Raeliva cheaper?

▾

Oak Longevity has the lower starting price (from $79/mo vs $117/mo for Raeliva). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Oak Longevity and Raeliva both offer?

▾

Both platforms treat Weight Loss / GLP-1, Longevity & Peptides. Oak Longevity covers 3 treatment categories total and Raeliva covers 2.

Still deciding?